Mnemosyne Pharmaceuticals Inc raised $6,000,000 on , from Atlas Venture, Clal Biotechnology ....

Get alertedif Mnemosyne Pharmaceuticals Inc gets funded!
Industry:Industrial and energy
United States
Rhode Island
Key people:Jessica Barnes (Director)
James Bristol (Director)
Jared Fertman (Director)
Richard Horan (Director)
Frank Menniti (Executive Officer)
Kollol Pal (CEO, Director, Executive Officer)
Frank S. Menniti (Chief Scientific Officer)
Data sources: - #startupcrunch Mnemosyne closes on additional $6M in Series A funding - smart science Mnemosyne closes on additional $6M in Series A funding - Providence Business News - Congrats Kollol and team! Great Friday News! Mnemosyne closes on additional $6M in Series A funding - Mnemosyne Pharmaceuticals Inc. Completes $6.0 Million Expansion of Series A Financing - Mnemosyne adds $6M in Series A expansion, raised $5.4M in Feb 2012 - Mnemosyne Gets Financing for Schizophrenia and Rett Syndrome Treatments: This latest round of Series A financi...
A 6M funding round was completed by Mnemosyne Pharmaceuticals Inc, a Providence, United States-based enterprise specializing in Industrial and energy. The transaction took place in June 21st, 2013.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!